Chemical Genomics Paradigm for Epigenetic Regulation

表观遗传调控的化学基因组学范式

• 批准号: 8332917
• 负责人: Ming-Ming Zhou
• 金额: $ 93.74万
• 依托单位: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-24 至 2012-02-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8332917
• 关键词: Acetylation; Address; Affinity; Binding; Bioinformatics; Biological Process; Biology; Biomedical Research; Bromodomain; Cell physiology; Cells; Chemicals; Chromatin; Code; Collaborations; Combinatorial Synthesis; Complex; Computing Methodologies; Couples; Cytosine; DNA; DNA Modification Process; DNA Sequence; Development; Emerging Technologies; Enzymes; Epigenetic Process; Family; Family Sizes; Feedback; Functional disorder; Gene Activation; Gene Expression Regulation; Gene Silencing; Generations; Genes; Genetic Transduction; Genomics; Goals; Health; Heterochromatin; Histones; Human; Human Genome; Investigation; Knowledge; Lead; Ligands; Link; Lysine; Mammalian Cell; Mediating; Medicine; Methodology; Methods; Methylation; Modeling; Modification; Molecular Biology; Molecular Profiling; Mutagenesis; Nuclear; PCAF gene; PHD Finger; Phosphorylation; Physiological; Polycomb; Protein Binding; Proteins; Reading; Regulation; Research; Research Personnel; Site; Stem cells; Stimulus; Structure; Structure-Activity Relationship; Subgroup; System; Technology; Tertiary Protein Structure; Transcriptional Activation; Transfection; Translating; Ubiquitination; Work; Yeasts; base; complex biological systems; design; epigenomics; genome sequencing; genome-wide; histone modification; histone-binding proteins; human disease; improved; innovation; novel; novel strategies; response; scaffold; small molecule; tool

DESCRIPTION (provided by applicant): The grand challenge in post genomic biomedical research is to translate the information encoded in genes and gene products of the human genome into an understanding of their functions in cellular physiology and patho- physiology, and into new approaches to medicine. However, our current knowledge is limited about the regulation and transduction of the genetic information that is believed to be governed by heritable information not encoded in the genomic DNA sequence - the essence of epigenetics. The long-term goal of our research is to develop innovative tools and technologies for the genomic scale study of epigenetic regulation of the human genome. Recent studies show that gene activation or silencing in response to physiological and environmental stimuli is dictated by chemical modifications of the DNA (i.e. methylation of cytosine) and of the chromosomal DNA-packing histones (i.e. acetylation, methylation, phosphorylation and ubiquitination). A unifying model has emerged to suggest an "epigenetic code" embedded in chromatin that signifies regions of distinct nuclear activities such as heterochromatin formation or transcriptional activation. This enigmatic code is established by chromatin modifying enzymes and interpreted by proteins that bind the chromatin in a modification-sensitive manner. The discovery of the methyl-CpG binding domain, the bromodomain that "reads" acetyl-lysine in histones, and the chromodomain or the PHD finger for methyl-lysine provides supporting evidence for this working hypothesis. To understand the fundamental principles that govern epigenetic gene regulation, new methodologies and innovative tools are needed for genome-wide investigation of chromosomal proteins in physiological conditions as pertained to the epigenetic regulation. Towards this goal, we propose to develop a new chemical genomics paradigm for structure-based functional design of small-molecule probes for histone binding proteins. This paradigm relies on a coherent set of experimental and computational methods of structural and chemical biology, and molecular/cell chromatin biology that are being developed in collaborations among the key investigators focused on the study of this system. As the new paradigm couples ligand design to genome-wide functional profiling of chromosomal proteins in epigenetic control, we term it Chemical Epigenomics. We expect that the new chemical tools and technologies emerging from this study will help address questions such as how histone modifications lead to regulatory capabilities of the chromatin in directing gene silencing or activation. We aim to attain the following three Specific Aims: 1. Genome-wide profiling of chromosomal protein domains in histone recognition 2. Structure-based functional design of chemical probes 3. Chemical epigenomics study of histone-directed chromatin biology PUBLIC HEALTH RELEVANCE: The regulation and transduction of genetic information of the human genome, of which our current knowledge is limited despite the available near complete genome sequence information, is governed by information not only encoded in the DNA sequence, but also by the epigenetic information that is heritable in the complex chemical modifications of the DNA as well as the chromosomal DNA-packing histones. In this project, we propose to develop innovative tools and technologies that are required for the generation of an extremely large amount of new knowledge on structure-function and mechanisms of chromosomal proteins on the genomic scale, and also the means to develop novel selective small-molecule chemical probes to enable investigation of biological functions of chromosomal proteins in their endogenous forms and under physiological conditions as pertained to the epigenetic gene regulation a new genomics research paradigm we term Chemical Epigenomics. We expect that the emerging inferences on the Chemical Epigenomics study of the histone- directed chromatin biology have broad implications on further investigations that range from new understanding of the fundamental human epigenetics, stem cell identity and fate to the new development of novel epigenetic therapies to human disease.

描述（由申请人提供）：后基因组生物医学研究的巨大挑战是将人类基因组的基因和基因产物中编码的信息转化为对它们在细胞生理学和病理生理学中的功能的理解，并转化为新的医学方法。然而，我们目前的知识是有限的关于遗传信息的调节和转导，这被认为是由基因组DNA序列中未编码的遗传信息所控制的-表观遗传学的本质。我们研究的长期目标是为人类基因组表观遗传调控的基因组规模研究开发创新工具和技术。最近的研究表明，响应于生理和环境刺激的基因激活或沉默由DNA的化学修饰（即胞嘧啶的甲基化）和染色体DNA包装组蛋白的化学修饰（即乙酰化、甲基化、磷酸化和泛素化）决定。一个统一的模型已经出现，提出了一个“表观遗传密码”嵌入在染色质，标志着不同的核活动，如异染色质形成或转录激活的区域。这种神秘的密码由染色质修饰酶建立，并由以修饰敏感方式结合染色质的蛋白质解释。甲基-CpG结合结构域、“读取”组蛋白中乙酰基-赖氨酸的溴结构域以及甲基-赖氨酸的染色体结构域或PHD指的发现为这一工作假设提供了支持证据。为了理解支配表观遗传基因调控的基本原理，需要新的方法和创新的工具来在生理条件下对染色体蛋白质进行全基因组研究，如与表观遗传调控有关的。为了实现这一目标，我们建议开发一种新的化学基因组学范式，用于组蛋白结合蛋白的小分子探针的基于结构的功能设计。这种模式依赖于一套连贯的实验和计算方法的结构和化学生物学，分子/细胞染色质生物学，正在开发的合作之间的主要研究人员集中在这个系统的研究。作为新的范例夫妇配体设计的全基因组功能分析的染色体蛋白质在表观遗传控制，我们称之为化学表观基因组学。我们期望这项研究中出现的新化学工具和技术将有助于解决诸如组蛋白修饰如何导致染色质在指导基因沉默或激活中的调节能力等问题。我们的目标是实现以下三个具体目标： 1.组蛋白识别中染色体蛋白质结构域的全基因组分析 2.基于结构的化学探针功能设计 3.组蛋白指导的染色质生物学的化学表观基因组学研究 公共卫生关系：人类基因组的遗传信息的调节和转导，我们目前的知识是有限的，尽管可用的接近完整的基因组序列信息，不仅是由DNA序列中编码的信息，但也由表观遗传信息，是遗传在复杂的化学修饰的DNA以及染色体DNA包装组蛋白。在这个项目中，我们提出开发创新的工具和技术，这些工具和技术是在基因组规模上产生大量关于染色体蛋白质的结构-功能和机制的新知识所必需的，以及开发新型选择性小分子-分子化学探针，使研究染色体蛋白质的生物功能，在其内源性形式和生理条件下，表观遗传基因调控是一种新的基因组学研究范式，我们称之为化学表观基因组学。我们期望，对组蛋白指导的染色质生物学的化学表观基因组学研究的新兴推论对进一步的研究具有广泛的影响，这些研究的范围从对基本人类表观遗传学、干细胞身份和命运的新理解到对人类疾病的新型表观遗传疗法的新发展。